AVI 6110
Alternative Names: AVI-6110Latest Information Update: 18 Sep 2023
At a glance
- Originator Avixgen
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Brain disorders
Most Recent Events
- 03 Jul 2023 Preclinical trials in Brain disorders in South Korea (unspecified route) (Avixgen pipeline, July 2023)